מדינה: ניו זילנד
שפה: אנגלית
מקור: Medsafe (Medicines Safety Authority)
Cefazolin sodium 1048mg equivalent to 1 g cephazolin
Teva Pharma (New Zealand) Limited
Cefazolin sodium 1048 mg (equivalent to 1 g cephazolin)
1 g
Powder for injection
Active: Cefazolin sodium 1048mg equivalent to 1 g cephazolin
Vial, glass, Type III 1g, 5 dose units
Prescription
Prescription
ACS Dobfar SpA
Respiratory Tract Infections Due to S. pneumoniae, Klebsiella sp, H. influenzae, Staph. aureus (including penicillinase-producing strains), and Group A ?-haemolytic streptococci. Injectable penicillin G benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.
Package - Contents - Shelf Life: Vial, glass, Type III 1g - 5 dose units - 36 months from date of manufacture stored at or below 25°C 36 hours reconstituted stored at or below 30°C 96 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light 12 weeks reconstituted stored below -20°C (Deep freeze)
1999-10-01
Data Sheet – New Zealand Hosp 3.0 1 DBL™ CEPHAZOLIN SODIUM FOR INJECTION 500 MG AND 1 G VIALS PRESENTATION DBL™ Cephazolin Sodium for Injection 500 mg and 1 g vials contain a white to slightly yellow powder which reconstitutes with Sterile Water for Injection to give a colourless solution. DBL™ Cephazolin Sodium for Injection 500 mg vial contains cephazolin sodium equivalent to 500 mg of cephazolin. DBL™ Cephazolin Sodium for Injection 1 g vial contains cephazolin sodium equivalent to 1 g of cephazolin. USES ACTIONS DBL™ Cephazolin Sodium for Injection is a semisynthetic cephalosporin for intramuscular or intravenous administration. _In vitro_ tests demonstrate that the bactericidal action of cephalosporins results from inhibition of cell-wall synthesis. DBL™ Cephazolin Sodium for Injection is active against the following organisms _in vitro_ and in clinical infections: _Staphylococcus aureus_ (including penicillinase-producing strains), _Staphylococcus epidermidis_. Group A β-haemolytic streptococci and other strains of streptococci (many strains of enterococci are resistant). _Streptococcus pneumoniae_ _Escherichia coli_ _Klebsiella sp._ _Proteus mirabilis_ _Haemophilus influenzae_ _Enterobacter aerogenes_ Most strains of indole-positive _Proteus (Proteus vulgaris)_, _Enterobacter cloacae_, _Morganella morganii_, and _Providencia rettgeri_ are resistant. Methicillin-resistant staphylococci, _Serratia_, _Pseudomonas_ and _Acinetobacter calcoaceticus_ (formerly _Mima_ and _Herellea sp_.) are almost uniformly resistant to cephazolin. Disc Susceptibility Tests--Quantitative methods that require measurement of zone diameters give the most precise estimates of antibiotic susceptibility. One such procedure has been recommended for use with discs for testing suscepti קרא את המסמך השלם